A Justice Department unit that handles criminal and civil enforcement of U.S. food and drug safety laws is being disbanded as ...

After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...

An investigation into the agency’s repeated violations of its own rules to approve addictive drugs—and its ongoing failure to ...

Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a fir ...